Perspective on the future use of genomics in exercise prescription.
about
Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status.Research in the exercise sciences: where we are and where do we go from here--Part IIGenetic architecture of voluntary exercise in an advanced intercross line of mice.AKT1 G205T genotype influences obesity-related metabolic phenotypes and their responses to aerobic exercise training in older CaucasiansRelationship between circulating progenitor cells, vascular function and oxidative stress with long-term training and short-term detraining in older men.A comparison of the genetic and clinical profile of men that respond and do not respond to the immediate antihypertensive effects of aerobic exercise.The influence of participant characteristics on the relationship between cuff pressure and level of blood flow restrictionCNTF 1357 G -> A polymorphism and the muscle strength response to resistance training.Genetic research and testing in sport and exercise science: a review of the issues.Human genetic variation: new challenges and opportunities for doping control.High responders and low responders: factors associated with individual variation in response to standardized training.Genetics of muscle strength and power: polygenic profile similarity limits skeletal muscle performance.Tuning of mitochondrial pathways by muscle work: from triggers to sensors and expression signatures.Maintenance of exercise training benefits is associated with adequate milk and dairy products intake in elderly hypertensive subjects following detraining.Commentary on Viewpoint: Perspective on the future use of genomics in exercise prescriptionGenetics and sport performance: current challenges and directions to the future
P2860
Q33533455-E7967E2D-001B-42D5-9960-7C7D0D91A29FQ33757414-1A314733-6B3F-400A-AF44-0C1D450CFBE4Q34545242-AD34BFF7-D2AB-4AB4-B93D-322029CBDAC0Q34786288-A2CBBCAE-5C5E-4880-AF2D-64F2672A87FCQ35178727-6A025C6D-0501-4314-85B4-471064E9D664Q36925058-61A90EED-3658-4999-A212-9BE3D8895090Q37014382-AB800883-59D8-44FA-B4DD-347854CA1485Q37391906-11963D06-39E5-42CD-A404-DFBAADB3854EQ37590719-A6E1AED9-F359-4AF8-8F7F-9E33B24BDDC6Q38017318-8A45706B-A412-4FB0-BFEB-BC9ACF1CFD19Q38210168-DF2D04E9-F0B6-47FD-86AD-BCACBB815811Q39714368-29B30F77-1B93-45F9-B4F8-F694989F2319Q47781343-41380F17-A1E1-424B-AC9E-F4C3A5ED3231Q50221912-552B24EB-6988-45D8-9AE4-5A6B1C572450Q57303491-B6FFAB18-3CA7-47E5-800A-50B22EB2DD25Q58885361-4A4F3872-B5ED-4A9E-8737-D68E1BD2B3B1
P2860
Perspective on the future use of genomics in exercise prescription.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Perspective on the future use of genomics in exercise prescription.
@en
type
label
Perspective on the future use of genomics in exercise prescription.
@en
prefLabel
Perspective on the future use of genomics in exercise prescription.
@en
P2860
P1476
Perspective on the future use of genomics in exercise prescription
@en
P2093
Stephen M Roth
P2860
P304
P356
10.1152/JAPPLPHYSIOL.01000.2007
P407
P577
2007-11-29T00:00:00Z